frakefamide
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Mu opioid receptorAGONIST
OPRM agonist
Chemistry & pharmacology
Loading structure…
SMILES
C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O- Mol. weight
- 563.63 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3989481 ↗
- ChEMBLCHEMBL2105081 ↗
Also known as
- bch-3963
- bch-3963
- frakefamide
- frakefamide
- frakefamide
- h-tyr-(d)-ala-(pf)phe-phe-nh2 hydrochloride
- lef-576
- lef-576
- spd-759
- spd-759